Sciele Pharma and Plethora Solutions Announce Positive Phase III … – Business Wire (press release)
Nov.07, 2008 in
News
 Business Wire (press release) | Sciele Pharma and Plethora Solutions Announce Positive Phase III ... Business Wire (press release), CA - There are currently no approved pharmaceutical treatments for premature ejaculation. PSD502 is applied locally "on demand" and is effective within five ... Plethora: Plethora reports positive outcomes of European Phase III ... |
Leave a Reply